Exactly one year after the “Liberation Day” announcement, the Trump administration has dropped a massive new trade bomb targeting the pharmaceutical and metals industries. This move aims to bypass previous court strikes and force global production  back to U.S. soil.

• The “Produce or Pay” Pharma Ultimatum: Foreign manufacturers of patented drugs now face a staggering 100% tariff. To avoid this, they must either cut prescription prices via government deals AND move production to the U.S.
• Strategic Ally Exceptions: Not everyone gets hit with the 100% rate. Branded drug tariffs are capped at 15% for the EU, Japan, South Korea, and Switzerland. The UK secured a special 0% tariff deal for three years by committing to build U.S. factories.
• Metals “Value” Loophole Closed: While the 50% duty remains on steel, aluminum, and copper, the tax is now calculated based on the U.S. sales price, not the declared import value. This stops importers from “low-balling” values to pay less tax.
• “Right-Sizing” the Burden: Tariffs on derivative products (like tractor parts or sinks) were halved to 25%. Items with less than 15% metal content (like dental floss cutters) are now completely tariff-free.
• Infrastructure Boost: To aid data centers and the power grid, duties on heavy industrial equipment were slashed from 50% to 15% through 2027.